Pancreatic cancer device delivers chemo directly to tumor, aims to reduce side effects
Disease control
Recruiting now
This early-phase study tests a new device that is surgically placed on the pancreas to deliver the chemotherapy drug gemcitabine directly to the tumor. The goal is to see if this approach is safe and tolerable for people with advanced pancreatic cancer that cannot be removed by s…
Phase: PHASE1 • Sponsor: Continuity Biosciences, LLC • Aim: Disease control
Last updated May 17, 2026 11:35 UTC